β¨ Pharmaceutical Product Listings
20 APRIL
NEW ZEALAND GAZETTE
939
Product: Zeldox
Active Ingredient(s): Ziprasidone hydrochloride (monohydrate) 22.65mg equivalent to 20mg ziprasidone
Dosage Form: Capsule
New Zealand Sponsor: Pfizer Laboratories Limited
Manufacturer(s): Heinrich Mack Nachf, Illertissen, Bavaria, Germany
Pfizer Pty Limited, West Ryde, New South Wales, Australia
Product: Zeldox
Active Ingredient(s): Ziprasidone hydrochloride (monohydrate) 45.3mg equivalent to 40mg ziprasidone
Dosage Form: Capsule
New Zealand Sponsor: Pfizer Laboratories Limited
Manufacturer(s): Heinrich Mack Nachf, Illertissen, Bavaria, Germany
Pfizer Pty Limited, West Ryde, New South Wales, Australia
Product: Zeldox
Active Ingredient(s): Ziprasidone hydrochloride (monohydrate) 67.95mg equivalent to 60mg ziprasidone
Dosage Form: Capsule
New Zealand Sponsor: Pfizer Laboratories Limited
Manufacturer(s): Heinrich Mack Nachf, Illertissen, Bavaria, Germany
Pfizer Pty Limited, West Ryde, New South Wales, Australia
Product: Zeldox
Active Ingredient(s): Ziprasidone hydrochloride (monohydrate) 90.6mg equivalent to 80mg ziprasidone
Dosage Form: Capsule
New Zealand Sponsor: Pfizer Laboratories Limited
Manufacturer(s): Heinrich Mack Nachf, Illertissen, Bavaria, Germany
Pfizer Pty Limited, West Ryde, New South Wales, Australia
Dated this 15th day of April 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2894
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the schedule hereto:
Schedule
Product: Abelcet
Active Ingredient(s): Amphotericin B 5mg/mL
Dosage Form: Emulsion for infusion
New Zealand Sponsor: Amgen New Zealand Branch Amgen Australia Pty Limited
Manufacturer(s): The Liposome Company Inc, Indianapolis, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Hemohes
Active Ingredient(s): Pentastarch 10%w/v
Dosage Form: Solution for injection
New Zealand Sponsor: Biomed Limited
Manufacturer(s): Biomed Limited, Pt Chevalier, Auckland
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Pentaspan
Active Ingredient(s): Pentastarch 100mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boots Healthcare Medical N Z Div. Boots Healthcare Australia
Manufacturer(s): NPBI BV, Runde, Emmer-Compascuum, The Netherlands
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 15th day of April 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2893
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 42
Gazette.govt.nz —
NZ Gazette 2000, No 42
β¨ LLM interpretation of page content
π₯
Pharmaceutical Product Listings
(continued from previous page)
π₯ Health & Social Welfare15 April 2000
Medicines, Pharmaceutical products, Sponsors, Manufacturers
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare15 April 2000
Medicines, Provisional Consent, Sponsors, Manufacturers
- G. R. Boyd, Chief Advisor, Safety and Regulation